24 jul: Europa/luk: Ingen lindring for investorerne
25 jul: Kalender - onsdag den 25 juli
25-07-2012 05:44:00

ASX Releases New 25% Capital Raising Rules for Smaller Companies

Relateret indhold

By Caroline Henshaw

SYDNEY--Australia's dominant exchange operator on Wednesday released the outcome of its controversial new plans to make it easier for small to medium sized companies to raise capital for investment.

From next month, the new rules will allow companies outside of the ASX Ltd.'s (ASX.AU) top 300 stocks with a market cap of less than 300 million Australian dollars ($307 million) to raise up to a quarter of their market capital through placements every 12 months, up from the current cap of 15%.

But in an amendment to the original plans put forward in April designed to placate existing investors, ASX will require boards to seek a special resolution backed by at least 75% of shareholders at an annual general meeting for the placements, rather than a simple majority through an ordinary resolution.

The additional shares can only be issued at a maximum 25% discount to the market price and boards must also provide shareholders with details of the purpose, affect and allocation of the new shares.

ASX said in a statement that the rules "strike a balance between protecting the interests of shareholders and facilitating timely capital raisings by listed companies," and "will help keep Australia a leading market to list, raise funds and invest." The rules will be reviewed in two years, it added.

Write to Caroline Henshaw at caroline.henshaw@wsj.com

Subscribe to WSJ: http://online.wsj.com?mod=djnwires

(END) Dow Jones Newswires

July 24, 2012 23:44 ET (03:44 GMT)

Copyright (c) 2012 Dow Jones & Company, Inc.

Opret kommentar

Relateret debat

  • 1 uge
  • 1 måned
  • 1 År
Ingen indlæg

Fondsbørsmeddelelser

Novo: Sanofi får europæisk godkendelse af Tresiba-konkurrent

28-04-2015 15:44:47
Det franske medicinalselskab Sanofi har fået marketingtilladelse til Toujeo - Insulin Glargin - i Europa.Det oplyser Sanofi tirsdag eftermiddag.- EU-godkendelse..

Merck leverer bedre end ventet og opjusterer - NY

28-04-2015 13:22:27
Det amerikanske medicinalselskab Merck kom pænt ud af første kvartal, hvor selskabet leverede noget bedre end ventet på bundlinjen. Samtidig løfter Merck sin pr..

Aktier/middag: Bøtten vendt på hovedet for C20 Cap

28-04-2015 11:07:14
Gassen er gået af ballonen for de danske aktier tirsdag, efter at mandagen bød på rekord nummer 28 i 2015 for C20 Cap-indekset, der blev sendt til vejrs af oplø..

Mest læste nyheder

  • 24 timer
  • 48 timer
  • 1 uge
1
Aktier/middag: Bøtten vendt på hovedet for C20 Cap
2
Aktier/tendens: Royal Unibrew i fokus i rødt Europa
3
Vind: Brasiliansk auktion skuffer fælt
4
Novo: Liraglutide kan måske anvendes til leversygdom - medie
5
Aktionæroprør i Topsil: Vil sælge virksomheden

Relaterede aktiekurser

ASX FPO 42,96 0,0% Aktiekurs uændret

Køb- og salgsanbefalinger

  • Trend
  • Pengemaskinen

Copyright Euroinvestor A/S 2015  Disclaimer Privatlivspolitik
Aktieinformation leveres af Interactive Data.
Data er forsinket 15-20 minutter iht. de enkelte børsers regler om videredistribution.
 
28. april 2015 20:18:31
(UTC+01:00) Brussels, Copenhagen, Madrid, Paris
Version: LiveBranchBuild_20150424.2 - EUROWEB5 - 2015-04-28 20:18:31 - 2015-04-28 20:18:31 - 1 - Website: OKAY

Når du besøger Euroinvestor.dk accepterer du, at der anvendes cookies, som vi og vores samarbejdspartnere benytter til funktionalitet, statistik og markedsføring. Læs mere om cookies på Euroinvestor.dk her

x